Skip to content
Abierto
Menu

Special notice

Gallup Access Business Subscription

75F40125R00025

Food and Drug Administration, FDA Center for Drug Evaluation and Research. All Other Professional, Scientific, and Technical Services.

View on SAM.govMarkdown

Response deadline

December 19, 2024 at 10:00 AM EST

Closed 637 days ago. Posted December 12, 2024. Scheduled to archive January 3, 2025.

Description

As published on SAM.gov.

In accordance with FAR 16.505(a)(4), the action being proposed for approval is a Justification & Approval (J&A) of a Brand Name acquisition. The nature and purpose of this document is to delineate in writing the justification and approval (J&A) of a Brand Name acquisition for the renewal of fifty (50) Gallup Access workplace surveys and one (1) Gallup access CliftonStrengths as described in the Statement of Work (SOW). The award is anticipated to be a Purchase Order (PO). The Government intends to solicit and award directly to Gallup, Inc.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. December 12, 2024

    Special notice

    Due December 19, 2024 at 10:00 AM EST. SAM.gov, notice 6adb88e3a7bd4e9db10a5ffd9e6f98f5

Points of contact